Design, synthesis, and characterization of (1-(4-aryl)-1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis

Overview of attention for article published in Drug Design, Development and Therapy, August 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 41 publications that cite this research output.

41

The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.

Unveiling the impact: A decade review on dihydropyrimidinones (DHPMs) to combat breast cancer

Article in Journal of Molecular Structure (July 2024)

Strategic One-Pot Synthesis of 1,2,3-Triazole-Based Dihydropyrimidinone Hybrids Using Magnetic CuFe2O4 NPS as Heterogeneous Catalyst and Their DFT, Molecular Docking Studies

Article in Journal of Molecular and Engineering Materials (April 2024)

A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity

Article in Chemistry & Biodiversity (March 2024)